Rights & Issues Investment Trust (LON:RIII - Get Free Report) shot up 1.8% on Thursday . The stock traded as high as GBX 2,255.24 ($30.30) and last traded at GBX 2,254.88 ($30.30). 1,971 shares were traded during mid-day trading, a decline of 56% from the average session volume of 4,487 shares. The stock had previously closed at GBX 2,215 ($29.76).
Rights & Issues Investment Trust Stock Up 1.9%
The firm has a market cap of £106.30 million, a PE ratio of 6.99 and a beta of 0.74. The firm has a 50-day moving average price of GBX 2,134.89 and a two-hundred day moving average price of GBX 2,024.88.
About Rights & Issues Investment Trust
(
Get Free Report)
Rights and Issues Investment Trust Public Limited Company is a self-managed investment trust. The firm invests in public equity markets of the United Kingdom. It invests in stocks of small-cap companies. The firm benchmarks the performance of its portfolio against the FTSE All share index. Rights and Issues Investment Trust Public Limited Company was founded in 1963 and is based in London, United Kingdom.
Further Reading
Before you consider Rights & Issues Investment Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rights & Issues Investment Trust wasn't on the list.
While Rights & Issues Investment Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access